MedPath

Study held to see the effect of intake of Dhatryadi decoction in the treatment of infection in urinary tract

Phase 2/3
Recruiting
Conditions
Urinary tract infection, site notspecified. Ayurveda Condition: Pittaja Mutrakricchra,
Registration Number
CTRI/2020/11/029119
Lead Sponsor
Anjali Rajesh Pote
Brief Summary

The aim of the study to see the effectiveness of Dhatryadi Kashaya in the management of Pittaja Mutrakricchra. The study will be conducted with 32 patients showing signs and symptoms of Pittaja Mutrakricchra, they will be administered with Dhatryadi Kashaya twice a day along with 4gm of sugar for 14 days and follow up will be done on 7 and 14 days and conclusion will be drawn on the basis of proper statistical methods.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
32
Inclusion Criteria
  • 1)Selection of patient will be irrespective of gender, religion and socio-economical class.
    1. Patients with the symptoms like painful micturition, burning micturition, hesitancy, urgency of urine will be selected.
    1. Patients who are willing to enroll in the research and sign the consent form.
Exclusion Criteria
  • 1)Patients with sepsis and renal failure, all immuno-compromised patients will be excluded.
    1. Known pregnant women will be excluded.
  • 3)Patients of diabetes mellitus will be excluded.
  • 4)Urethral stricture.
  • 5)Prostatomegaly.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dhatryadi Kashaya is effective in the management of Pittaja Mutrakricchra14 days study with 2 follow ups(0,7,14 days)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dr D Y Patil College Of Ayurved And research Centre Pimpri Pune

🇮🇳

Pune, MAHARASHTRA, India

Dr D Y Patil College Of Ayurved And research Centre Pimpri Pune
🇮🇳Pune, MAHARASHTRA, India
Anjali Rajesh Pote
Principal investigator
7743886706
anjupote@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.